Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,263,052
-$2,635,041 QoQ
Shares Held
49,573
-38.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#527
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. GILD ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
49,573 | $6,263,052 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,263,052 | 49,573 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $8,898,093 | 80,163 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,055,909 | 27,563 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,776,579 | 42,629 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,953,530 | 31,975 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,596,440 | 30,969 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,303,649 | 33,576 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,076,417 | 28,347 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,163,197 | 39,047 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,517,309 | 33,591 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,846,727 | 101,813 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,632,102 | 19,671 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,552,768 | 18,087 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,584,872 | 41,901 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,533,811 | 105,708 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,460,397 | 276,878 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,718,512 | 175,162 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,468,057 | 192,814 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,803,202 | 258,542 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,996,615 | 232,038 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,255,150 | 141,695 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,439,160 | 70,251 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,329,941 | 69,274 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,425,353 | 45,818 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||